IM Cannabis (IMCC) - 2024 Q4 - Annual Report

Exhibit 99.1 IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit. TORONTO, Ontario and GLIL YAM, Israel, March 31, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce its financial results for the fourth quarter and year e ...